Togo vs Zimbabwe: Population requiring preventive chemotherapy for schistosomiasis
Togo
3.19 million
in 2024
Zimbabwe
2.71 million
in 2024
Togo rank
25th
Zimbabwe rank
27th
Population requiring preventive chemotherapy for schistosomiasis over time
- Togo
- Zimbabwe
How they compare
Togo currently reports 3.19 million against 2.71 million in Zimbabwe, a difference of 481,700.
That makes Togo's figure about 1.2 times Zimbabwe's.
The two have swapped places 3 times across 15 shared years of data; in 2010 it was Zimbabwe ahead.
Togo ranks 25th and Zimbabwe ranks 27th of 52 countries.
Across the 2 decades both report, Togo averaged higher in 1 and Zimbabwe in 1.
Head to head by decade
| Decade | Togo | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.69 million | 3.52 million | 832,899 | Zimbabwe |
| 2020s | 3.39 million | 2.82 million | 572,918 | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Togo or Zimbabwe?
- Togo, at 3.19 million against 2.71 million in Zimbabwe as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Togo and Zimbabwe?
- 481,700, with Togo ahead.
- How many years of comparable data are there for Togo and Zimbabwe?
- 15 years are reported by both, from 2010 to 2024.
- How do Togo and Zimbabwe rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Togo ranks 25th and Zimbabwe ranks 27th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.